12:34 PM EST - Optimi Health : Announced that it has entered into a supply agreement with SABI Mind, a Calgary-based clinic group providing psychedelic-assisted therapies.
The Company has signed an agreement which will provide SABI Mind’s trained clinical staff with supplies of GMP psilocybin and 3,4-Methylenedioxymethamphetamine, pending the anticipated approval of its previously announced licensing amendment, for use with approved patients via Health Canada’s Special Access Program, clinical trials, and academic studies. Optimi Health
shares C.OPTI are trading down one cent at $0.28.
